Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
4.02 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.30 | 19490988 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.82 | 17306315 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.85 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.86 | 17497229 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.94 | 16251483 12569548 18414634 16835338 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.44 | 19371607 12928151 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.98 | 18316065 18940202 17507914 17688650 20603192 18558336 18985861 18396377 19460635 19232924 15238991 16609825 18177632 18775368 17157402 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.23 | 17594078 20046352 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.61 | 8888407 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.76 | 15504454 17687452 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.88 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.88 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
4.88 | 16507464 17306315 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
2.77 | 15504454 18922899 17687452 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.42 | 18640142 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.68 | 15738583 19152805 17938729 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.64 | 18022660 16973168 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
3.00 | 6135515 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.81 | 20734317 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 16575769 8888407 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
12.56 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
12.56 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.75 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.75 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.75 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.45 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.64 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.53 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.09 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.91 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.78 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.60 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.67 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.50 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.57 | 8888407 18558336 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
6.17 | 6392382 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.41 | 17688650 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.80 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
2.98 | 9931084 16076760 11953799 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
5.11 | 16612254 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
6.17 | 16093927 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.53 | 16930632 12749816 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.39 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.39 | 16705839 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.77 | 17339181 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.61 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
5.09 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
5.09 | 16368122 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.74 | 2876784 6135515 2876786 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.87 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
2.21 | 19168569 17976673 17306315 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.44 | 18765137 18803445 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.40 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.33 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
4.27 | 15371236 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
12.21 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
12.21 | 18551238 7678174 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
8.18 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
8.18 | 16359493 8888407 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.78 | 17056641 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
10.06 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
10.06 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
2.83 | 17306315 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.62 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.53 | 16905509 6392382 15371236 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.37 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
3.55 | 16140617 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
4.41 | 21343184 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.15 | 12752131 11422049 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.58 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
11.20 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
11.20 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
11.20 | 14763951 11738929 17978042 16876388 3137016 15475178 11044598 1511512 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.82 | 17548696 6392382 18709164 19834688 16353154 16759981 17453740 16702368 17938729 17050553 15952646 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
3.15 | 17976673 16251483 17029826 19538983 17050553 15504454 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.06 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.15 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.85 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
5.06 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
9.03 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
9.03 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
9.03 | 11144890 19429237 19322015 18640142 17306315 17976673 15987713 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.13 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
13.86 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
13.86 | 10091137 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
5.28 | 17056641 |